SCHEMBL13108619

SCHEMBL13108619

CNC[C@H](CC(=O)OC)Nc1ccc(C#N)c(Cl)c1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ RORC P51449 5/20 0.40
▸ SLC22A12 Q96S37 2/20 0.40
▸ GAA P10253 3/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ LMNA P02545 1/20 0.40
▸ IDO1 P14902 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ MCL1 Q07820 1/20 0.39
▸ AR P10275 2/20 0.38
▸ S1PR3 Q99500 1/20 0.38
▸ MAPT P10636 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ GLA P06280 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ HPGD P15428 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27756872 1.00 RORC (0.40) RORCSLC22A12GAAALDH1A1LMNA
SCHEMBL13108623 0.89 AR (0.40) RORCSLC22A12GAAALDH1A1LMNA
SCHEMBL27756886 0.89 AR (0.40) RORCSLC22A12GAAALDH1A1LMNA
SCHEMBL13108633 0.89 RORC (0.41) RORCSLC22A12GAAALDH1A1LMNA
SCHEMBL27756864 0.89 RORC (0.41) RORCSLC22A12GAAALDH1A1LMNA
SCHEMBL3033130 0.88 S1PR3 (0.42) RORCSLC22A12GAAALDH1A1LMNA
SCHEMBL13108641 0.87 RORC (0.40) RORCSLC22A12GAAALDH1A1LMNA
SCHEMBL13108646 0.86 RORC (0.38) RORCSLC22A12GAAALDH1A1LMNA
SCHEMBL12345090 0.85 MEN1 (0.37) RORCSLC22A12GAAALDH1A1LMNA
SCHEMBL14300552 0.82 L3MBTL1 (0.37) GAAALDH1A1LMNAMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7816395-B2 Pyrrolidinone anilines as progesterone receptor modulators GLAXOSMITHKLINE LLC (US) 2010-10-19 — — US disclosed
CN-101522190-A Pyrrolidinone anilines as progesterone receptor modulators SMITHKLINE BEECHAM CORP (US) 2009-09-02 — — CN disclosed
US-20080039517-A1 PYRROLIDINONE ANILINES AS PROGESTERONE RECEPTOR MODULATORS GLAXOSMITHKLINE LLC 2008-02-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080039517-A1 PYRROLIDINONE ANILINES AS PROGESTERONE RECEPTOR MODULATORS PGR, PGRMC2, PGRMC1 RORC 266/4885SLC22A12 2181/4885GAA 4768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback